Charles River Innovates with Apollo™ Ecosystem for Enhanced Research

Charles River Introduces Apollo™ for Enhanced Client Engagement

Charles River Laboratories International, Inc. (NYSE: CRL) has unveiled the Apollo™ for CRADL®, an innovative cloud-based platform designed to optimize vivarium rental services for research clients. This platform offers a seamless experience for users, enabling them to access essential training, tools, and services required to ignite their research swiftly and efficiently.

Key Features of Apollo™ for CRADL®

Apollo™ acts as a dynamic companion to CRADL’s existing offerings, streamlining the research initiation process. Its centralized dashboard provides direct connectivity to online trainings, Charles River’s Research Models Online Ordering System, and crucial study support services. This unified platform facilitates a significant enhancement in the ease of onboarding for clients.

Insights from the Leadership

Mark Mintz, Corporate Senior Vice President and Chief Information Officer at Charles River, emphasized the transformative impact of Apollo, stating, "Apollo is the tech stack that is powering Charles River’s digital transformation. A high impact, iteratively expanded platform that gives clients greater access to data, products, and services, it enhances decision-making and speeds up operational processes, driving value for our clients and efficiencies in drug discovery and development."

Streamlined Operations for CRADL Clients

For clients involved in drug discovery programs, the Apollo platform simplifies and accelerates the onboarding process significantly. It empowers users with control over their reservations for technical services and equipment, promotes easy management of protocols, and improves communication with IACUC committees, thereby hastening the execution of research.

A Comprehensive Innovation Strategy

Apollo represents the latest addition to a suite of innovations introduced by Charles River to amplify client experiences and operational efficiencies. Below are some highlighted features offered in the Apollo ecosystem:

• Apollo for CRADL®: Eases administrative burdens associated with CRADL’s flexible vivarium rental options, allowing researchers to focus on their initiatives sooner, enhancing their overall productivity.
• Apollo for Safety Assessment: Speeds up the safety assessment process by providing real-time access to pivotal data visualization, necessary documentation, and planning tools.
• Apollo for Biologics: Offers a centralized hub for submitting sample forms, tracking samples, and exchanging documents efficiently, ensuring data accuracy and time savings.
• Apollo for Discovery: Delivers immediate access to oncology study pricing, facilitating faster planning and purchase processes through expert connections.
• Apollo for Logica®: Provides clients with adaptive and immediate updates for Logica® AI-driven small molecule projects, promoting flexibility in measurements of success.
• Research Models Online Ordering System: Integrates an interactive catalog with real-time inventory visibility linked to pricing, assisting clients in obtaining immediate order confirmations and a customized purchasing experience.

Charles River's Commitment to Client Success

Charles River is devoted to continually expanding the Apollo ecosystem to further enhance client experiences and boost efficiencies throughout various research stages. It reflects a growing trend within the life sciences industry, where digital transformation is playing a critical role in streamlining research efforts.

About CRADL®

CRADL®, or the Charles River Accelerator and Development Lab, serves as a premier facility for clients aiming to launch or extend their in vivo drug research programs. With access to an expansive range of integrated drug discovery and non-clinical development resources, CRADL operates nearly 30 facilities across significant biotech hubs worldwide.

About Charles River

With a mission to support pharmaceutical and biotechnology companies, as well as government agencies and academic institutions, Charles River offers pivotal products and services that expedite research and drug development. Their dedicated team strives to deliver exactly what clients need to foster breakthroughs in therapy development for those who depend on them.

Frequently Asked Questions

What is the Apollo™ platform offered by Charles River?

Apollo™ is a secure, cloud-based platform introduced by Charles River to streamline vivarium rental services and enhance client experiences in research.

How does Apollo™ benefit CRADL clients?

The platform simplifies onboarding and allows CRADL clients to manage reservations, protocols, and communication more efficiently, speeding up their research processes.

What features does Apollo™ include?

It incorporates various tools such as Research Models Online Ordering System, Apollo for Safety Assessment, and Apollo for Discovery, all aimed at enhancing research efficiency.

How does Charles River support drug discovery?

Charles River provides a comprehensive suite of products and services designed to help clients optimized their research from drug development stages to safe manufacturing methods.

Where are CRADL facilities located?

CRADL has nearly 30 facilities in key biotech hubs around the world, facilitating robust support for clients' in vivo drug research programs.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. If any of the material offered here is inaccurate, please contact us for corrections.